We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Medica Group Plc | LSE:MGP | London | Ordinary Share | GB00BYV24996 | ORD 0.2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 211.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMMGP
RNS Number : 0950F
Medica Group PLC
05 July 2023
Medica Group PLC
Director / PDMR Shareholding
Medica Group PLC (the "Company") announces that on 4 July 2023, the PDMRs listed below had options that vested and were exercised due to the approval of Scheme of Arrangement via Court Sanction hearing. The exercised options were ordinary shares of 0.2p each in the Company under the Company's Performance Share Plan 2017, Deferred Bonus Plan 2017 and Save As You Earn Scheme:
Name of PDMR Number of shares subject to options Stuart Quin 744,671 Richard Jones 545,399 Kevin Terrins 284,292 Sarah Burns 226,457 Marc O'Brien 288,130 Caroline Byrne 139,141 Rob Lavis 193,342 Fiona Carr 43,780 Kim Scanlan 32,905
The notifications set out below are provided in accordance with the requirements of the UK Market Abuse Regulation, and set out more details of the transactions.
1. Details of PDMR (a) Name 1. Stuart Quin 2. Richard Jones 3. Kevin Terrins 4. Sarah Burns 5. Marc O'Brien 6. Caroline Byrne 7. Rob Lavis 8. Fiona Carr 9. Kim Scanlan -------------------------- --------------------------------------------------------- 2. Reason for notification ------------------------------------------------------------------------------------- (b) Position / status 1. Chief Executive Officer 2. Chief Financial Officer 3. Group Director of Corporate Development 4. Managing Director, UK 5. Chief Information Officer 6. Managing Director, Ireland 7. Group Medical Director 8. Group Head of Human Resources 9. Managing Director, US -------------------------- --------------------------------------------------------- Initial notification Initial notification in each case / amendment -------------------------- --------------------------------------------------------- 3. Details of the Issuer ------------------------------------------------------------------------------------- (a) Name Medica Group PLC -------------------------- --------------------------------------------------------- (b) LEI 213800B8XE5FUSZF5Z16 -------------------------- --------------------------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) have been conducted ------------------------------------------------------------------------------------- (a) Description of Ordinary shares of 0.2p each in the the financial instrument capital of the Company ("Shares") -------------------------- --------------------------------------------------------- (b) Nature of the transaction Vesting and exercise of options over Shares pursuant to the Company's Performance Share Plan 2017 -------------------------- --------------------------------------------------------- (c) Price(s) and volume GBPNil Option Price in each case 1. 597,579 2. 454,832 3. 217,565 4. 175,869 5. 212,516 6. 85,323 7. 154,811 8. 37,141 9. 32,905 -------------------------- --------------------------------------------------------- (d) Aggregated information N/A -------------------------- --------------------------------------------------------- (e) Date of the transaction 4 July 2023 -------------------------- --------------------------------------------------------- (f) Place of the transaction Outside a trading venue -------------------------- --------------------------------------------------------- 1. Details of PDMR (a) Name 1. Stuart Quin 2. Richard Jones 3. Kevin Terrins 4. Sarah Burns 5. Marc O'Brien 6. Caroline Byrne 7. Rob Lavis 8. Fiona Carr 9. Kim Scanlan -------------------------- --------------------------------------------------------- 2. Reason for notification ------------------------------------------------------------------------------------- (b) Position / status 1. Chief Executive Officer 2. Chief Financial Officer 3. Group Director of Corporate Development 4. Managing Director, UK 5. Chief Information Officer 6. Managing Director, Ireland 7. Group Medical Director 8. Group Head of Human Resources 9. Managing Director, US -------------------------- --------------------------------------------------------- Initial notification Initial notification in each case / amendment -------------------------- --------------------------------------------------------- 3. Details of the Issuer ------------------------------------------------------------------------------------- (a) Name Medica Group PLC -------------------------- --------------------------------------------------------- (b) LEI 213800B8XE5FUSZF5Z16 -------------------------- --------------------------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) have been conducted ------------------------------------------------------------------------------------- (a) Description of Ordinary shares of 0.2p each in the the financial instrument capital of the Company ("Shares") -------------------------- --------------------------------------------------------- (b) Nature of the transaction Vesting and exercise of options over Shares pursuant to the Deferred Bonus Plan 2017 -------------------------- --------------------------------------------------------- (c) Price(s) and volume GBPNil Option Price in each case 1. 129,092 2. 82,006 3. 48,727 4. 42,027 5. 57,614 6. 53,818 7. 35,107 8. 5,725 9. - -------------------------- --------------------------------------------------------- (d) Aggregated information N/A -------------------------- --------------------------------------------------------- (e) Date of the transaction 4 July 2023 -------------------------- --------------------------------------------------------- (f) Place of the transaction Outside a trading venue -------------------------- --------------------------------------------------------- 1. Details of PDMR (a) Name 1. Stuart Quin 2. Richard Jones 3. Kevin Terrins 4. Sarah Burns 5. Marc O'Brien 6. Caroline Byrne 7. Rob Lavis 8. Fiona Carr 9. Kim Scanlan
-------------------------- --------------------------------------------------------- 2. Reason for notification ------------------------------------------------------------------------------------- (b) Position / status 1. Chief Executive Officer 2. Chief Financial Officer 3. Group Director of Corporate Development 4. Managing Director, UK 5. Chief Information Officer 6. Managing Director, Ireland 7. Group Medical Director 8. Group Head of Human Resources 9. Managing Director, US -------------------------- --------------------------------------------------------- Initial notification Initial notification in each case / amendment -------------------------- --------------------------------------------------------- 3. Details of the Issuer ------------------------------------------------------------------------------------- (a) Name Medica Group PLC -------------------------- --------------------------------------------------------- (b) LEI 213800B8XE5FUSZF5Z16 -------------------------- --------------------------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) have been conducted ------------------------------------------------------------------------------------- (a) Description of Ordinary shares of 0.2p each in the the financial instrument capital of the Company ("Shares") -------------------------- --------------------------------------------------------- (b) Nature of the transaction Vesting and exercise of options over Shares pursuant to the Save As Your Earn Scheme 2020 -------------------------- --------------------------------------------------------- (c) Price(s) and volume GBP1.00 Option Price in each case 1. 18,000 2. - 3. 18,000 4. - 5. 18,000 6. - 7. - 8. - 9. - -------------------------- --------------------------------------------------------- (d) Aggregated information N/A -------------------------- --------------------------------------------------------- (e) Date of the transaction 4 July 2023 -------------------------- --------------------------------------------------------- (f) Place of the transaction Outside a trading venue -------------------------- --------------------------------------------------------- 1. Details of PDMR (a) Name 1. Stuart Quin 2. Richard Jones 3. Kevin Terrins 4. Sarah Burns 5. Marc O'Brien 6. Caroline Byrne 7. Rob Lavis 8. Fiona Carr 9. Kim Scanlan -------------------------- --------------------------------------------------------- 2. Reason for notification ------------------------------------------------------------------------------------- (b) Position / status 1. Chief Executive Officer 2. Chief Financial Officer 3. Group Director of Corporate Development 4. Managing Director, UK 5. Chief Information Officer 6. Managing Director, Ireland 7. Group Medical Director 8. Group Head of Human Resources 9. Managing Director, US -------------------------- --------------------------------------------------------- Initial notification Initial notification in each case / amendment -------------------------- --------------------------------------------------------- 3. Details of the Issuer ------------------------------------------------------------------------------------- (a) Name Medica Group PLC -------------------------- --------------------------------------------------------- (b) LEI 213800B8XE5FUSZF5Z16 -------------------------- --------------------------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) have been conducted ------------------------------------------------------------------------------------- (a) Description of Ordinary shares of 0.2p each in the the financial instrument capital of the Company ("Shares") -------------------------- --------------------------------------------------------- (b) Nature of the transaction Vesting and exercise of options over Shares pursuant to the Save As Your Earn Scheme 2021 -------------------------- --------------------------------------------------------- (c) Price(s) and volume GBP1.46 Option Price in each case 1. - 2. 8,561 3. - 4. 8,561 5. - 6. - 7. 3,424 8. - 9. - -------------------------- --------------------------------------------------------- (d) Aggregated information N/A -------------------------- --------------------------------------------------------- (e) Date of the transaction 4 July 2023 -------------------------- --------------------------------------------------------- (f) Place of the transaction Outside a trading venue -------------------------- --------------------------------------------------------- 1. Details of PDMR (a) Name 1. Stuart Quin 2. Richard Jones 3. Kevin Terrins 4. Sarah Burns 5. Marc O'Brien 6. Caroline Byrne 7. Rob Lavis 8. Fiona Carr 9. Kim Scanlan -------------------------- --------------------------------------------------------- 2. Reason for notification ------------------------------------------------------------------------------------- (b) Position / status 1. Chief Executive Officer 2. Chief Financial Officer 3. Group Director of Corporate Development 4. Managing Director, UK 5. Chief Information Officer 6. Managing Director, Ireland 7. Group Medical Director 8. Group Head of Human Resources 9. Managing Director, US -------------------------- --------------------------------------------------------- Initial notification Initial notification in each case / amendment -------------------------- --------------------------------------------------------- 3. Details of the Issuer ------------------------------------------------------------------------------------- (a) Name Medica Group PLC -------------------------- --------------------------------------------------------- (b) LEI 213800B8XE5FUSZF5Z16 -------------------------- --------------------------------------------------------- 4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s) have been conducted ------------------------------------------------------------------------------------- (a) Description of Ordinary shares of 0.2p each in the the financial instrument capital of the Company ("Shares") -------------------------- --------------------------------------------------------- (b) Nature of the transaction Vesting and exercise of options over Shares pursuant to the Save As Your Earn Scheme 2022 -------------------------- --------------------------------------------------------- (c) Price(s) and volume GBP1.422 Option Price in each case 1. - 2. - 3. - 4. - 5. - 6. - 7. - 8. 914 9. - -------------------------- --------------------------------------------------------- (d) Aggregated information N/A -------------------------- --------------------------------------------------------- (e) Date of the transaction 4 July 2023 -------------------------- --------------------------------------------------------- (f) Place of the transaction Outside a trading venue -------------------------- ---------------------------------------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHNKPBNQBKDPOK
(END) Dow Jones Newswires
July 05, 2023 10:39 ET (14:39 GMT)
1 Year Medica Chart |
1 Month Medica Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions